| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.194 | 12.942 | 13.753 | 11.652 | 13.108 | 7.655 | 18.070 | 20.449 | 15.523 | 17.662 |
| Total Income - EUR | 9.284 | 13.036 | 13.754 | 11.653 | 13.200 | 7.657 | 18.070 | 22.412 | 17.274 | 18.272 |
| Total Expenses - EUR | 7.450 | 12.367 | 9.456 | 6.387 | 5.744 | 6.100 | 9.470 | 16.647 | 18.645 | 16.800 |
| Gross Profit/Loss - EUR | 1.834 | 670 | 4.298 | 5.265 | 7.455 | 1.557 | 8.600 | 5.765 | -1.370 | 1.472 |
| Net Profit/Loss - EUR | 1.556 | 279 | 3.885 | 4.915 | 7.059 | 1.337 | 8.220 | 5.436 | -1.517 | 1.298 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Claudani Evermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 298 | 0 | 392 |
| Current Assets | 2.080 | 4.479 | 8.309 | 9.682 | 9.525 | 1.794 | 9.594 | 6.141 | 2.124 | 3.259 |
| Inventories | 1.497 | 0 | 0 | 0 | 0 | 0 | 97 | 97 | 97 | 0 |
| Receivables | 0 | 0 | 0 | 165 | 183 | 207 | 156 | 2.703 | 347 | 208 |
| Cash | 582 | 4.479 | 8.309 | 9.517 | 9.342 | 1.587 | 9.342 | 3.340 | 1.680 | 3.051 |
| Shareholders Funds | -2.133 | -1.832 | 2.084 | 6.961 | 9.363 | 1.379 | 9.568 | 5.476 | 1.406 | 2.541 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.213 | 6.312 | 6.225 | 2.721 | 162 | 415 | 32 | 973 | 718 | 1.109 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4939 - 4939" | |||||||||
| CAEN Financial Year |
4939
|
|||||||||
Comments - Claudani Evermed Srl